Dr Narinder Singh Grewal, MD | |
23861 Mcbean Pkwy, Valencia, CA 91355-2058 | |
(661) 288-5700 | |
(661) 288-5703 |
Full Name | Dr Narinder Singh Grewal |
---|---|
Gender | Male |
Speciality | Pain Management |
Experience | 46 Years |
Location | 23861 Mcbean Pkwy, Valencia, California |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1396783270 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208VP0014X | Pain Medicine - Interventional Pain Medicine | C42572 (California) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Narinder S Grewal M D A Medical Corporation | 2769573559 | 5 |
News Archive
Reinforcing its commitment to the 10 million customers it serves daily, Sodexo, Inc., leading provider of Quality of Daily Life Solutions, recently obtained ISO (International Organization of Standardization) 22000:2005 certification for its food management systems in the U.S. and Canada, which focuses on ensuring food safety and quality from farm to fork.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that it has received preliminary results from a Phase II clinical trial of GDC-0449 from Roche and Genentech, Curis' collaborator and a member of the Roche Group.
New laboratory findings at the University of Illinois at Chicago suggest that what lies outside cancer cells is at least as important as the genes inside in explaining a tumor's malignancy.
A team from the University of Illinois at Urbana-Champaign and Northwestern University has devised a novel nuclear magnetic resonance imaging technique that delivers a roughly 10-nanometer spatial resolution.
› Verified 5 days ago
Entity Name | Narinder S Grewal M D A Medical Corporation |
---|---|
Entity Type | Part B Supplier - Ambulatory Surgical Center |
Entity Identifiers | NPI Number: 1699720573 PECOS PAC ID: 2769573559 Enrollment ID: O20070808000531 |
News Archive
Reinforcing its commitment to the 10 million customers it serves daily, Sodexo, Inc., leading provider of Quality of Daily Life Solutions, recently obtained ISO (International Organization of Standardization) 22000:2005 certification for its food management systems in the U.S. and Canada, which focuses on ensuring food safety and quality from farm to fork.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that it has received preliminary results from a Phase II clinical trial of GDC-0449 from Roche and Genentech, Curis' collaborator and a member of the Roche Group.
New laboratory findings at the University of Illinois at Chicago suggest that what lies outside cancer cells is at least as important as the genes inside in explaining a tumor's malignancy.
A team from the University of Illinois at Urbana-Champaign and Northwestern University has devised a novel nuclear magnetic resonance imaging technique that delivers a roughly 10-nanometer spatial resolution.
› Verified 5 days ago
Entity Name | Narinder S Grewal M D A Medical Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1629553730 PECOS PAC ID: 2769573559 Enrollment ID: O20200416002981 |
News Archive
Reinforcing its commitment to the 10 million customers it serves daily, Sodexo, Inc., leading provider of Quality of Daily Life Solutions, recently obtained ISO (International Organization of Standardization) 22000:2005 certification for its food management systems in the U.S. and Canada, which focuses on ensuring food safety and quality from farm to fork.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that it has received preliminary results from a Phase II clinical trial of GDC-0449 from Roche and Genentech, Curis' collaborator and a member of the Roche Group.
New laboratory findings at the University of Illinois at Chicago suggest that what lies outside cancer cells is at least as important as the genes inside in explaining a tumor's malignancy.
A team from the University of Illinois at Urbana-Champaign and Northwestern University has devised a novel nuclear magnetic resonance imaging technique that delivers a roughly 10-nanometer spatial resolution.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Narinder Singh Grewal, MD 23861 Mcbean Pkwy Ste A1, Valencia, CA 91355-2003 Ph: (661) 288-7978 | Dr Narinder Singh Grewal, MD 23861 Mcbean Pkwy, Valencia, CA 91355-2058 Ph: (661) 288-5700 |
News Archive
Reinforcing its commitment to the 10 million customers it serves daily, Sodexo, Inc., leading provider of Quality of Daily Life Solutions, recently obtained ISO (International Organization of Standardization) 22000:2005 certification for its food management systems in the U.S. and Canada, which focuses on ensuring food safety and quality from farm to fork.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that it has received preliminary results from a Phase II clinical trial of GDC-0449 from Roche and Genentech, Curis' collaborator and a member of the Roche Group.
New laboratory findings at the University of Illinois at Chicago suggest that what lies outside cancer cells is at least as important as the genes inside in explaining a tumor's malignancy.
A team from the University of Illinois at Urbana-Champaign and Northwestern University has devised a novel nuclear magnetic resonance imaging technique that delivers a roughly 10-nanometer spatial resolution.
› Verified 5 days ago